Deep Profiling of B Cells Responding to Various Pathogens Uncovers Key Memory and Antibody Secreting Lineages

Medical News: Scientists Unlock Secrets of B Cells in Human Immunity
Researchers from Amsterdam UMC, Sanquin Blood Bank, and the Public Health Service of Amsterdam have conducted an in-depth study revealing crucial insights into how B cells respond to different pathogens. The study provides a detailed look into how these immune cells transition into memory B cells (MBCs) and antibody-secreting cells (ASCs), offering valuable information for vaccine development and disease monitoring.


Deep Profiling of B Cells Responding to Various Pathogens Uncovers Key Memory and Antibody Secreting Lineages

Understanding the way B cells develop is essential for improving vaccination strategies and long-term immune protection. This Medical News report highlights key findings from the research, which analyzed B cell responses to both prepandemic pathogens such as influenza and respiratory syncytial virus (RSV) and newly encountered viruses like SARS-CoV-2. By using advanced spectral flow cytometry, the researchers identified distinct B cell subsets, shedding light on the mechanisms guiding their differentiation.
 
Identifying the Key Players in B Cell Immunity
The study revealed the existence of a specific activated B cell subset, identified as CD43+CD71+IgG+, which serves as a critical juncture in the differentiation process of MBCs and ASCs. This subset was found to be highly enriched for SARS-CoV-2 specificities, suggesting a significant role in the body’s immune response to recent infections.
 
Further classification of these B cells based on markers such as CD86 revealed two distinct pathways. The CD86+ subset showed a strong resemblance to ASCs, which are responsible for producing antibodies, while the CD86- subset shared characteristics with IgG+ MBCs. These findings indicate a crucial decision-making process within the immune system, where certain B cells become long-lived memory cells while others transform into active antibody producers.
 
The Role of Antigen Exposure in B Cell Differentiation
One of the major discoveries of the study was how the timing and nature of antigen exposure shape B cell differentiation. Researchers found that B cells responding to recently encountered SARS-CoV-2 antigens exhibited different characteristics compared to those responding to prepandemic antigens.

The study categorized IgG+ MBCs into two groups:
 
-Activated MBCs (AMBCs): These cells (CD73-/CD24lo) were primarily SARS-CoV-2-specific, meaning they were generated in response to recent infections.
 
-Resting MBCs (RMBCs): These cells (CD73+/CD24hi) were more likely to recognize antigens from past infections, such as influenza and RSV, indicating a long-term immune memory.
 
A particularly interesting finding was the identification of a CD95- subcluster within the RMBC population, which accounted for more than 40% of prepandemic-specific cells. This suggests that some B c ells have the ability to retain immunological memory for extended periods, potentially lasting years or even decades.
 
The Connection Between Disease Severity and B Cell Activity
The study also explored the impact of disease severity on B cell activity. Individuals who had recovered from severe COVID-19 infections exhibited a significantly higher frequency of antigen-specific B cells compared to those who had milder cases. The SARS-CoV-2-specific B cells in these individuals showed stronger binding to viral proteins, indicating higher affinity and a more robust immune response.
 
The researchers noted that 11 to 20 weeks after infection, activated B cells were still detectable, suggesting an ongoing germinal center reaction - a process where B cells undergo mutation and selection to enhance their ability to fight pathogens. This continuous evolution of B cells could explain why some individuals develop long-lasting immunity after infection.
 
Unraveling the Pathways of Memory B Cell Formation
By analyzing different subpopulations within the IgG+ MBC pool, the study provided new insights into how B cells mature over time. The researchers identified a phenotypic transition from activated B cells to resting memory B cells, with AMBCs acting as an intermediate stage.
 
Three major IgG+ B cell populations were identified:
-Activated B Cells (ActBCs): Recently emerged from germinal center reactions, capable of differentiating into ASCs or MBCs depending on the presence of specific markers.
 
-Activated Memory B Cells (AMBCs): These cells still displayed some activation markers but were transitioning toward a more stable memory state.
 
-Resting Memory B Cells (RMBCs): Considered true long-lived memory cells, primarily responding to antigens encountered long ago.
 
The study found that the presence of CD24 and CD73 markers helped distinguish between these populations. Resting memory B cells showed a unique expression pattern of CD95-, CD73+, and CD24lo, indicating a stable and long-lived immune memory.
 
Implications for Future Research and Vaccine Development
The findings of this study provide a valuable framework for understanding the body’s immune response and could have significant implications for vaccine development. Monitoring these B cell subsets can help scientists evaluate the effectiveness of vaccines and identify optimal time points for booster shots.
 
Furthermore, tracking activated B cells over time could serve as an indicator of ongoing immune activity, helping researchers develop strategies to enhance long-term immunity. The ability to distinguish between different B cell subsets may also aid in the study of autoimmune diseases, cancers, and other conditions where immune regulation plays a critical role.
 
Conclusion
This study represents a major step forward in our understanding of how B cells differentiate and function in response to infections. By uncovering distinct subsets of memory and antibody-secreting B cells, the research provides a clearer picture of how long-term immunity is established.
 
The identification of key markers such as CD43, CD71, CD86, CD24, and CD73 opens new avenues for future research. These findings not only enhance our knowledge of immune system function but also offer practical applications in vaccine development and immune monitoring.
 
With further studies, scientists may be able to refine vaccination strategies to optimize long-lasting immunity and improve the body's ability to fight infections effectively. As the field of immunology advances, insights from studies like this will continue to shape our approach to public health and disease prevention.
 
The study findings were published in the peer-reviewed journal: Science Advances.
https://www.science.org/doi/10.1126/sciadv.ado1331
 
For the latest on Immunology, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/new-insights-into-how-natural-killer-cells-fight-viral-infections
 
https://www.thailandmedical.news/news/japanese-study-finds-that-covid-19-infections-and-vaccines-are-inducing-the-emergence-of-atypical-memory-b-cells
 
https://www.thailandmedical.news/news/study-finds-that-30-percent-of-human-anti-glycan-antibodies-fail-to-activate-the-complement-system
 
https://www.thailandmedical.news/articles/immunology
 
https://www.thailandmedical.news/pages/thailand_doctors_listings